LoginSignup
Edwards Lifesci logo

Edwards Lifesci Stock

StockStock
ISIN: US28176E1082
Ticker: EW
US28176E1082
EW

Price

Frequently asked questions

What is Edwards Lifesci's market capitalization?

The market capitalization of Edwards Lifesci is $40.37B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Edwards Lifesci's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Edwards Lifesci is 9.67. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Edwards Lifesci?

Edwards Lifesci's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.932. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Edwards Lifesci's stock?

Currently, 29 analysts cover Edwards Lifesci's stock, with a consensus target price of $96.12. Analyst ratings provide insights into the stock's expected performance.

What is Edwards Lifesci's revenue over the trailing twelve months?

Over the trailing twelve months, Edwards Lifesci reported a revenue of $5.62B.

What is the EBITDA for Edwards Lifesci?

Edwards Lifesci's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.67B. EBITDA measures the company's overall financial performance.

What is the 5-year beta of Edwards Lifesci's stock?

The 5-year beta for Edwards Lifesci is 1.12. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Edwards Lifesci have, and what sector and industry does it belong to?

Edwards Lifesci employs approximately 19,800 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Edwards Lifesci's shares?

The free float of Edwards Lifesci is 596.96M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $40.37B

5Y beta

 1.12

EPS (TTM)

 $6.932

Free Float

 596.96M

P/E ratio (TTM)

 9.67

Revenue (TTM)

 $5.62B

EBITDA (TTM)

 $1.67B

Pricing

1D span
$66.76$67.31
52W span
$58.93$96.12

Analyst Ratings

The price target is $96.12 and the stock is covered by 29 analysts.

Buy

16

Hold

11

Sell

2

Information

Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.

19,800

Medical Equipment & Supplies

Health Care

Identifier

ISIN

US28176E1082

Primary Ticker

EW

Knockouts

Join the conversation
Sign upLogin